このエントリーをはてなブックマークに追加
ID 34987
本文ファイル
著者
Nagao, Saeko
Hattori, Noboru
Kanehara, Masashi
Ishikawa, Nobuhisa
キーワード
Lung cancer
Bone metastasis
Zoledronic acid
Anti-tumor effect
NDC
医学
抄録(英)
Bisphosphonates are widely used for the treatment of metastatic skeletal tumors and hypercalcemia resulting from malignant tumors. Zoledronic acid (ZOL), a third-generation bisphosphonate agent, was recently demonstrated to show synergistic antitumor activity of ZOL when combined with chemotherapy in lung cancer patients. However, whether ZOL exerts direct antitumor activity on lung cancer remains unclear. Here, we report an atypical case encountered while treating a 57-year-old woman with pulmonary adenocarcinoma and multiple metastases of the liver, left adrenal gland, and bone. The nonskeletal lesions, consisting of the primary lesion and hepatic metastasis, regressed after treatment with ZOL alone. We believe this case demonstrates a possible antitumor effect of ZOL against lung cancer.
掲載誌名
Hiroshima Journal of Medical Sciences
60巻
1号
開始ページ
7
終了ページ
9
出版年月日
2011-03
出版者
Hiroshima University Medical Press
ISSN
0018-2052
NCID
言語
英語
NII資源タイプ
紀要論文
広大資料タイプ
学内刊行物(紀要等)
DCMIタイプ
text
フォーマット
application/pdf
著者版フラグ
publisher
権利情報
(c) Hiroshima University Medical Press.
部局名
医歯薬学総合研究科
他の一覧